StockSelector.com
  Research, Select, & Monitor Tuesday, May 21, 2019 7:48:06 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Obalon Therapeutics, Inc.$0.38($.01)(2.56%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Obalon Therapeutics, Inc. has an overall rank of 5923 out of 6850 stocks based on 6 positive rankings and 7 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $3.00 for Obalon Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Obalon Therapeutics is ranked 4.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Obalon Therapeutics is ranked 399.
Price-to-Book
Obalon Therapeutics rank is 545
Estimated Revenue Growth
Obalon Therapeutics rank is 630
Oversold Stochastics
Obalon Therapeutics rank is 753
Price-to-Sales
Obalon Therapeutics rank is 1497
Negative Rankings
90 Day Loss
Obalon Therapeutics rank is 37
Negative ROE
Obalon Therapeutics rank is 127
Negative ROA
Obalon Therapeutics rank is 202
Negative Net Margin
Obalon Therapeutics rank is 286
10 Day Loss
Obalon Therapeutics rank is 309
Down EPS Surprise
Obalon Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
Obalon Therapeutics rank is 2189







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.